Experimental hepatitis B drug might offer 'functional cure' for a subset of patients
- Posted on May 28, 2026
- By The Toronto Star
- 1 Views
- 1 min read
Experimental hepatitis B drug might offer 'functional cure' for a subset of patients
WASHINGTON (AP) — A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver virus, what’s called a “functional cure,” researchers reported
